House Advances Bill Safeguarding State Cannabis Laws

The House of Representatives voted 397-28 to pass a spending bill that maintains protections preventing the Justice Department from interfering with state medical marijuana programs.

The overwhelming bipartisan vote continues a policy that has been included in federal spending bills since 2014, when the Rohrabacher-Farr amendment first prohibited DOJ from using funds to prevent states from implementing medical cannabis laws.

Notably, the bill does not include language that would have blocked the Trump administration's efforts to reschedule cannabis from Schedule I to Schedule III.

Medical Marijuana Protections

The provision prohibits the Justice Department from spending money to prevent states "from implementing their own laws that authorize the use, distribution, possession, or cultivation of medical marijuana."

In practical terms, this means federal prosecutors cannot target state-legal medical marijuana operators who are complying with state law. The protection applies to medical programs only—recreational cannabis operations remain technically vulnerable to federal enforcement, though the Biden administration has indicated it won't prioritize such cases.

Rep. Earl Blumenauer, a longtime cannabis reform advocate, said: "This bill represents a critical step in respecting state laws and the will of the voters."

Rescheduling Not Blocked

Earlier versions of the spending bill included language that would have prevented DOJ from using funds for cannabis rescheduling efforts. That provision was removed before the final vote.

The removal signals congressional willingness to allow the rescheduling process to proceed. The DEA is currently reviewing public comments on the proposed move of cannabis from Schedule I to Schedule III—a change that would acknowledge medical value and ease some restrictions.

The exclusion "could facilitate future efforts to reclassify cannabis under the Controlled Substances Act," policy experts noted.

What It Means

For state medical marijuana programs, the provision provides continued certainty that the federal government won't interfere with operations. 38 states have legalized medical cannabis, and the protection has helped those programs expand without fear of federal crackdowns.

The bill now moves to the Senate, which is expected to pass similar language. President Biden would then need to sign it into law.

For the cannabis industry, the overwhelming vote margin (397-28) demonstrates strong congressional support for allowing states to set their own cannabis policies—at least for medical programs.

---

This article is based on original reporting by Marijuana Moment.